Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
Titel:
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis
Auteur:
Wang, Michael Robak, Tadeusz Maddocks, Kami J. Phillips, Tycel Smith, Stephen D. Gallinson, David Calvo, Roser Wun, Chuan-Chuan Munugalavadla, Veerendra Jurczak, Wojciech